Equifax faced mixed price-target updates from analysts, with Baird shaving its target to $232 from $245 and Needham maintaining a Buy rating while setting a new target around $245. The company also reported stronger-than-expected quarterly results, delivering $2.25 per share on $1.70 billion in revenue, amid a chorus of updated ratings from several banks.
